Source: International Congress 2018 – New methods and concepts in tests of lung and respiratory muscle function
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Levesque (Montréal, Canada), C. Poirier (Montréal, Canada), B. Dube (Montréal, Canada). Dose omission to shorten methacholine challenge testing: clinical consequences and safety of the use of a "10% fall in FEV1" threshold. 2409

Member's Comments

No comment yet.

Related content which might interest you: How often FEV1 underestimates bronchodilator response? Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003 Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018 Year: 2019 Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma Source: International Congress 2018 – Clinical markers of asthma Year: 2018 ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests Source: Eur Respir J, 49 (5) 1601526; 10.1183/13993003.01526-2016 Year: 2017 ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests Source: Guideline 2017 Year: 2017 IsovolumeFEF25-75%6 and FEV1 for identifying bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 156s Year: 2006 Airway responsiveness to hypertonic saline: dose-response slope or PD15? Source: Eur Respir J 2005; 25: 153-158 Year: 2005 Should use of 4 hours continuous positive airway pressure per night be considered acceptable compliance? Source: Eur Respir J 2014; 44: 1119-1120 Year: 2014 Slow or forced inspiration for a bronchodilator response test (BRT) in COPD? Source: Eur Respir J 2002; 20: Suppl. 38, 301s Year: 2002 Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 What constitutes a rapid fall in serial FEV1? Source: Eur Respir J 2003; 22: Suppl. 45, 118s Year: 2003 CAPTAIN: Relationship between FEV1 reversibility at screening as a continuous variable and treatment response Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Changes in FEV1 over time in COPD and the importance of spirometry reference ranges: the devil is in the detail Source: Breathe, 15 (4) 337; 10.1183/20734735.0252-2019 Year: 2019 Forced oscillation technique: an alternative outcome measure for methacholine provocation test. Source: International Congress 2017 – Best abstracts in lung function Year: 2017 The (un)importance of the time-interval between inhalation and FEV1 measurement in a methacholine challenge test Source: Eur Respir J 2004; 24: Suppl. 48, 183s Year: 2004 Assessing response to methacholine challenges using a new forced oscillation device Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception Year: 2016 Correlation of airway obstruction and patient-reported endpoints in clinical studies Source: Eur Respir J 2001; 17: 220-224 Year: 2001 Bronchodilation test in COPD: effect of inspiratory manoeuvre preceding forced expiration Source: Eur Respir J 2003; 21: 82-85 Year: 2003 Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016